Skip to main content
. 2024 Apr 15;15(3):454–462. doi: 10.14740/wjon1829

Table 2. OS Based on Metastasis Site (N = 318).

Topography of metastases Number Events Median survival (months) P
Bone metastases 0.460
  No 129 66 27.6
  Yes 179 101 29.0
Liver metastases 0.120
  No 222 115 30.1
  Yes 93 55 22.5
CNS metastases 0.022*
  No 297 158 29.1
  Yes 18 12 6.9
Cutaneous-subcutaneous metastases 0.029*
  No 271 140 29.4
  Yes 37 27 17.2
Lung metastases 0.006*
  No 216 109 30.1
  Yes 93 58 21.4

*P < 0.05. OS: overall survival; CNS: central nervous system.